These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 10443548

  • 21. Denervation changes in normal and myasthenia gravis human muscle fibres during organ culture.
    Cull-Candy SG, Miledi R, Uchitel OD.
    J Physiol; 1982 Dec; 333():227-49. PubMed ID: 7182466
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor.
    Uchitel O, Engel AG, Walls TJ, Nagel A, Atassi MZ, Bril V.
    Muscle Nerve; 1993 Dec; 16(12):1293-301. PubMed ID: 8232384
    [Abstract] [Full Text] [Related]

  • 26. Reduction of miniature end-plate potential amplitude in extraocular and limb muscles in an animal model of myasthenia gravis.
    Zahm DS, Kim YI, Liu HH, Johns TR.
    Exp Neurol; 1983 Apr; 80(1):258-62. PubMed ID: 6832272
    [Abstract] [Full Text] [Related]

  • 27. Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.
    Farrugia ME, Kennett RP, Newsom-Davis J, Hilton-Jones D, Vincent A.
    Muscle Nerve; 2006 Apr; 33(4):568-70. PubMed ID: 16382443
    [Abstract] [Full Text] [Related]

  • 28. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R, Plomp JJ, Huijbers MG, Niks EH, Straasheijm KR, Detmers FJ, Hermans PW, Sleijpen K, Verrips A, Losen M, Martinez-Martinez P, De Baets MH, van der Maarel SM, Verschuuren JJ.
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [Abstract] [Full Text] [Related]

  • 29. The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates.
    ter Beek WP, Martínez-Martínez P, Losen M, de Baets MH, Wintzen AR, Verschuuren JJ, Niks EH, van Duinen SG, Vincent A, Molenaar PC.
    Am J Pathol; 2009 Oct; 175(4):1536-44. PubMed ID: 19745065
    [Abstract] [Full Text] [Related]

  • 30. Decreased number of acetylcholine receptors is the mechanism that alters the time course of muscle relaxants in myasthenia gravis: a study in a rat model.
    De Haes A, Proost JH, De Baets MH, Stassen MH, Houwertjes MC, Wierda JM.
    Eur J Anaesthesiol; 2005 Aug; 22(8):591-6. PubMed ID: 16119595
    [Abstract] [Full Text] [Related]

  • 31. Immunochemical properties of junctional and extrajunctional acetylcholine receptor.
    Dwyer DS, Bradley RJ, Furner RL, Kemp GE.
    Brain Res; 1981 Jul 27; 217(1):23-40. PubMed ID: 6167329
    [Abstract] [Full Text] [Related]

  • 32. Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors.
    Oda K, Lambert EH, Lennon VA, Palmer AC.
    Muscle Nerve; 1984 Jul 27; 7(9):705-16. PubMed ID: 6543919
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T, Raftery MA.
    J Supramol Struct; 1980 Jul 27; 14(3):267-79. PubMed ID: 6971372
    [Abstract] [Full Text] [Related]

  • 34. Quantitative study of motor endplates in muscle fibres dissociated by a simple procedure.
    Robbins N, Olek A, Kelly SS, Takach P, Christopher M.
    Proc R Soc Lond B Biol Sci; 1980 Oct 15; 209(1177):555-62. PubMed ID: 6107922
    [Abstract] [Full Text] [Related]

  • 35. Acetylcholinesterase histochemistry in the non-endplate region of skeletal muscles and effect of denervation.
    Nakano S, Akiguchi I, Yasuda Y, Nakamura S, Kameyama M, Kimura J.
    Muscle Nerve; 1990 Aug 15; 13(8):687-96. PubMed ID: 2166910
    [Abstract] [Full Text] [Related]

  • 36. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
    Hall ZW, Pizzighella S, Gu Y, Vicini S, Schuetze SM.
    Ann N Y Acad Sci; 1987 Aug 15; 505():272-85. PubMed ID: 2446552
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
    Losen M, Stassen MH, Martínez-Martínez P, Machiels BM, Duimel H, Frederik P, Veldman H, Wokke JH, Spaans F, Vincent A, De Baets MH.
    Brain; 2005 Oct 15; 128(Pt 10):2327-37. PubMed ID: 16150851
    [Abstract] [Full Text] [Related]

  • 39. Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle.
    Johnson BR, Kim YI, Sanders DB.
    J Neurol Sci; 1983 Jun 15; 59(3):431-40. PubMed ID: 6875609
    [Abstract] [Full Text] [Related]

  • 40. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.
    Fambrough DM, Drachman DB, Satyamurti S.
    Science; 1973 Oct 19; 182(4109):293-5. PubMed ID: 4742736
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.